These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 194026)

  • 21. Modulation of myocardial alpha 1- but not beta-adrenoceptors after 90-day tail-suspension.
    Chen J; Zhang LF; Han C; Yu GS; Ma J
    J Gravit Physiol; 1996 Apr; 3(1):57-62. PubMed ID: 11539308
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thermodynamic properties of agonist interactions with the beta adrenergic receptor-coupled adenylate cyclase system. II. Agonist binding to soluble beta adrenergic receptors.
    Contreras ML; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Apr; 237(1):165-72. PubMed ID: 2870175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
    Aarons RD; Nies AS; Gal J; Hegstrand LR; Molinoff PB
    J Clin Invest; 1980 May; 65(5):949-57. PubMed ID: 6102572
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):34-46. PubMed ID: 39246
    [No Abstract]   [Full Text] [Related]  

  • 25. Reconstitution of beta-adrenergic receptors into phospholipid vesicles: restoration of [125I]iodohydroxybenzylpindolol binding to digitonin-solubilized receptors.
    Fleming JW; Ross EM
    J Cyclic Nucleotide Res; 1980; 6(6):407-19. PubMed ID: 6260843
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.
    Goretzki PE; Wahl RA; Branscheid D; Roeher HD
    Surgery; 1984 Dec; 96(6):1001-8. PubMed ID: 6150553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential reduction of binding of 125I-iodopindolol to beta-1 adrenoceptors in the amygdala of rat after antidepressant treatments.
    Ordway GA; Gambarana C; Tejani-Butt SM; Areso P; Hauptmann M; Frazer A
    J Pharmacol Exp Ther; 1991 May; 257(2):681-90. PubMed ID: 1674532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neonatal rat pinealocytes: typical and atypical characteristics of [125I]iodohydroxybenzylpindolol binding and adenosine 3',5'-monophosphate accumulation.
    Auerbach DA; Klein DC; Woodard C; Aurbach GD
    Endocrinology; 1981 Feb; 108(2):559-67. PubMed ID: 6256156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Beta 1- and beta 2-adrenergic receptors display subtype-selective coupling to Gs.
    Green SA; Holt BD; Liggett SB
    Mol Pharmacol; 1992 May; 41(5):889-93. PubMed ID: 1350321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
    Jasper JR; Motulsky HJ; Insel PA
    J Pharmacol Exp Ther; 1988 Mar; 244(3):820-4. PubMed ID: 2908047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative antihypertensive effects and tissue distribution of beta adrenergic blocking drugs.
    Garvey HL; Ram N
    J Pharmacol Exp Ther; 1975 Jul; 194(1):220-33. PubMed ID: 1151751
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thyroid status and adrenergic receptor subtypes in the rat: comparison of receptor density and responsiveness.
    Fox AW; Juberg EN; May JM; Johnson RD; Abel PW; Minneman KP
    J Pharmacol Exp Ther; 1985 Dec; 235(3):715-23. PubMed ID: 3001274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of human platelet beta-adrenergic receptors using 125I-labeled cyanopindolol and 125I-labeled hydroxybenzylpindolol.
    Steer ML; Atlas D
    Biochim Biophys Acta; 1982 Apr; 686(2):240-4. PubMed ID: 6282327
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of beta-adrenergic receptor subtypes in human post-mortem brain: alterations in limbic regions of schizophrenics.
    Joyce JN; Lexow N; Kim SJ; Artymyshyn R; Senzon S; Lawrence D; Cassanova MF; Kleinman JE; Bird ED; Winokur A
    Synapse; 1992 Mar; 10(3):228-46. PubMed ID: 1313605
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of photolabels to probe the Na,K-ATPase and the beta-adrenergic receptor.
    Ruoho AE; Hall CC; Rashidbaigi A
    Fed Proc; 1983 Aug; 42(11):2837-41. PubMed ID: 6307757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes.
    Hedberg A; Gerber JG; Nies AS; Wolfe BB; Molinoff PB
    J Pharmacol Exp Ther; 1986 Oct; 239(1):117-23. PubMed ID: 3020227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol.
    Ordway GA; Gambarana C; Frazer A
    J Pharmacol Exp Ther; 1988 Oct; 247(1):379-89. PubMed ID: 2845059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
    Mahan LC; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):7-15. PubMed ID: 2868411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tissue levels and displacement of in vivo labelled beta-adrenergic receptors by FM 24, an irreversible or slowly dissociable beta-blocker.
    Le Fur G; Paillard JJ; Rougeot C; Uzan A
    Eur J Pharmacol; 1980 Oct; 67(4):413-8. PubMed ID: 6108856
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Binding of 125I-iodohydroxybenzylpindolol to cerebral membranes: association with 5-hydroxytryptamine recognition sites as well as beta-adrenoceptors.
    Willcocks AL; Nahorski SR
    Biochem Pharmacol; 1983 Nov; 32(22):3311-9. PubMed ID: 6316978
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.